About this episode
President Trump raises global tariff to 15%. Novo Nordisk's weight-loss drug trial results disappoint.
And should you be looking outside of stocks right now
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Get every episode summarized
Each time Power Lunch publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from Power Lunch
Fed holds rates steady 4/29/26
Power Lunch
Apr 29, 202628:21failed
Stocks sell off as OpenAI report hits market 4/28/26
Power Lunch
Apr 28, 202649:28failed
Market waits for Big Tech earnings this week 4/27/26
Power Lunch
Apr 27, 202644:52failed
Semiconductor stocks keep surging 4/24/26
Power Lunch
Apr 24, 202642:31failed